SuperworthAxogen market cap AXGN
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $2B
- Highest close in our data
- $2.8B
- Aug 2026
Axogen is worth $2B at the close on Oct 23, 2026, at $38.06 a share.
That is up 145% over the last year and up 225% over five years.
Its highest close in our data was $2.8B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2B | $1.4B | $2.8B | +35% |
| 2025 | $1.5B | $443.1M | $1.5B | +106% |
| 2024 | $733.2M | $251.3M | $733.2M | +149% |
| 2023 | $294M | $160.3M | $455.4M | −30% |
| 2022 | $422M | $302.6M | $548.5M | +8% |
| 2021 | $389.4M | $389.4M | $963.6M | −46% |
| 2020 | $718.3M | $305.1M | $718.3M | −2% |
| 2019 | $734.1M | $458.9M | $991.9M | −2% |
| 2018 | $749.1M | $660.9M | $1.9B | −21% |
| 2017 | $946.8M | $306M | $946.8M | +220% |
| 2016 | $296.1M | $137.8M | $296.1M | +98% |
| 2015 | $149.4M | $61.8M | $168.6M | +115% |
| 2014 | $69.6M | $39.5M | $84.3M | +16% |
| 2013 | $60.2M | $32.2M | $77M | +107% |
| 2012 | $29.1M | $27.7M | $43.1M | −2% |
| 2011 | $29.6M | $8.6M | $32.3M | n/a |
Against its peers
Companies in Medical - Devices nearest Axogen's size, closest first, today.
| Company | Market cap |
|---|---|
| AXGNAxogen | $2B |
| TMDXTransMedics | $2.5B |
| CNMDCONMED | $1.5B |
| ITGRInteger | $4.3B |
| LIVNLivaNova | $4.5B |
| ZBHZimmer Biomet | $18.8B |
| ELMDElectromed | $220.6M |
| Peer median | $3.4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Axogen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.